BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2013
View Archived Issues
AN-162 shows potent inhibitory effects in prostate cancer models
Read More
Flexible dosing of insulin degludec achieves glycemic control
Read More
Safety, tolerability and pharmacokinetics of ONO-9054 reported
Read More
A novel Neto1-KO mouse model with schizophrenia-related behavioral phenotype
Read More
Fourth pivotal trial of Celgene's apremilast in psoriatic arthritis meets endpoints
Read More
Biomarker modulation seen in phase I trial of AZD-1208
Read More
Novel Youai compounds active against RAS-mutant cancers
Read More
Lundbeck updates accomplishments of first quarter 2013
Read More
Calithera Biosciences targets GLS with novel compounds
Read More
Novel kappa opioid receptor agonist shows promise in animal models of dermatitis
Read More
Novo Nordisk recaps progress of first quarter 2013
Read More
Nimbus Discovery and Shire to codevelop treatments for lysosomal storage disorders
Read More
Data monitoring committee recommends continuation of phase III GRIPHON study
Read More
GSK updates on plans to share detailed clinical trial data
Read More
Zhejiang Huahai and Oncobiologics sign alliance for biosimilar monoclonal antibodies
Read More
Investigator initiated study in triple-negative breast cancer starts in Japan
Read More
Array BioPharma patents new tyrosine-protein kinase inhibitors
Read More
Portola's PRT-4445 shown to reverse anticoagulant activity of Eliquis in phase II study
Read More
Concordia Pharmaceuticals acquires the rights to Shionogi products
Read More
Celsus reports interim data from phase II contact dermatitis study
Read More
Techulon receives DARPA contract for therapies aimed at multi-drug resistant bacteria
Read More
Boehringer Ingelheim joins Structural Genomics Consortium on drug discovery projects
Read More
Abbott obtains CE Mark for diabetes diagnostic
Read More
Aviir launches cardiovascular genetic testing services
Read More
OMI obtains grants for myalgic encephalomyelitis/chronic fatigue syndrome
Read More
Inovio Pharmaceuticals discloses novel DNA vaccines for arenavirus
Read More
New beta-lactamase inhibitors synthesized by Therabor Pharmaceuticals
Read More
Aileron Therapeutics creates HIF-inhibiting Stapled Peptide for cancer therapy
Read More
